Coronary no-reflow in the modern era: a review of advances in diagnostic techniques and contemporary management (original) (raw)

Non-pharmaco, non-invasive management of coronary no-reflow phenomenon

Santosh Sinha

Archives of Medical Sciences. Atherosclerotic Diseases, 2020

View PDFchevron_right

Prevention and Treatment of No-Reflow Phenomenon by Targeting the Coronary Microcirculation

Zsolt Bagi

Reviews in Cardiovascular Medicine, 2014

View PDFchevron_right

No-reflow phenomenon: Achilles' heel of primary coronary angioplasty in acute myocardial infarction

Jacek Kubica

Cardiology journal, 2008

View PDFchevron_right

Advances in the Assessment of No-Reflow After Successful Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction

Paul Grayburn

Journal of the American College of Cardiology, 2008

View PDFchevron_right

The no-reflow phenomenon in coronary arteries

Mauricio Cohen

Journal of Thrombosis and Haemostasis, 2004

View PDFchevron_right

The role of vasodilators in the prevention and treatment of no-reflow following percutaneous coronary intervention

Scott Harding

Heart, 2006

View PDFchevron_right

Incidence and treatment of 'no-reflow' after percutaneous coronary intervention

Richard Kuntz

Circulation, 1994

View PDFchevron_right

Clinical and Procedural Predictors of No-Reflow Phenomenon After Primary Percutaneous Coronary Interventions

ahmet güler

Circulation Journal, 2008

View PDFchevron_right

No-Reflow Phenomenon and Lesion Morphology in Patients With Acute Myocardial Infarction

Daiju Fukuda

Circulation, 2002

View PDFchevron_right

Impact of PercuSurge Device Conjugative With Intracoronary Administration of Nitroprusside on No-Reflow Phenomenon Following Primary Percutaneous Coronary Intervention

Chiung-Jen Wu

Circulation Journal, 2006

View PDFchevron_right

Assessment of no-reflow phenomenon after acute myocardial infarction with harmonic angiography and intravenous pump infusion with Levovist: Comparison with intracoronary contrast injection

Stefania Funaro

Journal of the American Society of Echocardiography, 2001

View PDFchevron_right

No-Reflow Phenomenon: Pathophysiology, Diagnosis, Prevention, and Treatment. A Review of the Current Literature and Future Perspectives

Plinio Cirillo

Angiology, 2014

View PDFchevron_right

Evaluation of the clinical and procedural predictive factors of no-reflow phenomenon following primary percutaneous coronary intervention

Hooman Bakhshande

Research in Cardiovascular Medicine, 2015

View PDFchevron_right

Role of adenosine as an adjunct therapy in the prevention and treatment of no-reflow phenomenon in acute myocardial infarction with ST segment elevation: review of the current data

Stefan Grajek

Kardiologia Polska, 2013

View PDFchevron_right

Management of two major complications in the cardiac catheterisation laboratory: the no-reflow phenomenon and coronary perforations

Mark Mason

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2008

View PDFchevron_right

Temporal evolution and functional outcome of no reflow: sustained and spontaneously reversible patterns following successful coronary recanalisation

Domenico Cianflone, italo porto

Heart, 2003

View PDFchevron_right

Clinical Experience with a Novel Intracoronary Perfusion Catheter to Treat No-Reflow Phenomenon in Acute Coronary Syndromes

Gabriel Maluenda

Journal of Interventional Cardiology, 2010

View PDFchevron_right

Clinical Predictors of No-Reflow in Percutaneous Coronary Intervention for Acute Myocardial Infarction

Jorge Szarfer

Argentine Journal of Cardiology, 2013

View PDFchevron_right

How an aggressive treatment of no-reflow phenomenon in primary percutaneous coronary intervention with high thrombus burden can achieve a grade III TIMI-flow : a case report

Januar Martha

2022

View PDFchevron_right

No-reflow phenomenon and comparison to the normal-flow population postprimary percutaneous coronary intervention for ST elevation myocardial infarction: case–control study (NORM PPCI)

Angela Hoye

Open Heart, 2020

View PDFchevron_right

Histopathological Findings of the No-reflow Phenomenon Following Coronary Intervention for Acute Coronary Syndrome

t h

International Heart Journal, 2005

View PDFchevron_right

Novel predictors and adverse long-term outcomes of No-reflow phenomenon in patients with acute ST elevation myocardial infarction undergoing primary percutaneous coronary intervention

Hanan Radwan

Indian Heart Journal, 2021

View PDFchevron_right

Unmet goals in the treatment of Acute Myocardial Infarction: Review

Alejandro Barbagelata

F1000Research, 2017

View PDFchevron_right

The Use of Intracoronary Sodium Nitroprusside to Treat No-Reflow after Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction

Vladan Vukcevic

Herz, 2010

View PDFchevron_right

No Reflow-phenomenon: from Current State of the Art to Future Perspectives

Armando Liso

AIMS Medical Science, 2015

View PDFchevron_right

Predictors and Outcomes of No-Reflow Phenomenon Following Primary Percutaneous Intervention for ST Elevation Myocardial Infarction

SciDoc Publishers

View PDFchevron_right

Safety and Efficacy of Intracoronary Vasodilators in the Treatment of No-Reflow after Primary Percutaneous Intervention in Patients with Acute ST-Elevation Myocardial Infarction: A Literature Review

mostafa Dastani

2016

View PDFchevron_right

No-Reflow Phenomenon After Acute Myocardial Infarction Is Associated With Reduced Clot Permeability and Susceptibility to Lysis

Anetta Undas

Arteriosclerosis, Thrombosis, and Vascular Biology, 2007

View PDFchevron_right